{
  "ticker": "CRL",
  "last_updated": "2025-04-15T16:12:15.965878",
  "retention_years": 3,
  "count": 326,
  "transactions": [
    {
      "id": 171929,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-10",
      "transaction_shares": "5916",
      "transaction_price": "215.19",
      "transaction_type": "M",
      "shares_after_transaction": "50365"
    },
    {
      "id": 171950,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-12-14",
      "transaction_shares": "3381",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "19887"
    },
    {
      "id": 171951,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-11-30",
      "transaction_shares": "1850",
      "transaction_price": "197.73",
      "transaction_type": "S",
      "shares_after_transaction": "23133"
    },
    {
      "id": 171947,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-11-14",
      "transaction_shares": "5620",
      "transaction_price": "178.05",
      "transaction_type": "P",
      "shares_after_transaction": "202643"
    },
    {
      "id": 171959,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-11-09",
      "transaction_shares": "9128",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "34111"
    },
    {
      "id": 123374,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-24",
      "transaction_shares": "1000",
      "transaction_price": "198.786",
      "transaction_type": "P",
      "shares_after_transaction": "1000"
    },
    {
      "id": 171967,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-24",
      "transaction_shares": "1000",
      "transaction_price": "198.786",
      "transaction_type": "P",
      "shares_after_transaction": "1000"
    },
    {
      "id": 123326,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-08-10",
      "transaction_shares": "700",
      "transaction_price": "216.52",
      "transaction_type": "S",
      "shares_after_transaction": "24983"
    },
    {
      "id": 123363,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "197023"
    },
    {
      "id": 123370,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-08-10",
      "transaction_shares": "1471",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "11411"
    },
    {
      "id": 123383,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "5763",
      "transaction_price": "217.24",
      "transaction_type": "S",
      "shares_after_transaction": "3592"
    },
    {
      "id": 171913,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-08-10",
      "transaction_shares": "700",
      "transaction_price": "216.52",
      "transaction_type": "S",
      "shares_after_transaction": "24983"
    },
    {
      "id": 171955,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "197023"
    },
    {
      "id": 171963,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-08-10",
      "transaction_shares": "1471",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "11411"
    },
    {
      "id": 171976,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-08-10",
      "transaction_shares": "5763",
      "transaction_price": "217.24",
      "transaction_type": "S",
      "shares_after_transaction": "3592"
    },
    {
      "id": 80756,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "95",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11600"
    },
    {
      "id": 123341,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "95",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11600"
    },
    {
      "id": 171928,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "95",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11600"
    },
    {
      "id": 80736,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-06-01",
      "transaction_shares": "1528",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9940"
    },
    {
      "id": 123320,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-06-01",
      "transaction_shares": "1528",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9940"
    },
    {
      "id": 171907,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-06-01",
      "transaction_shares": "1528",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9940"
    },
    {
      "id": 80752,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-31",
      "transaction_shares": "338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11505"
    },
    {
      "id": 123337,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-31",
      "transaction_shares": "338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11505"
    },
    {
      "id": 171924,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-31",
      "transaction_shares": "338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11505"
    },
    {
      "id": 80731,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-29",
      "transaction_shares": "1274",
      "transaction_price": "194.12",
      "transaction_type": "F",
      "shares_after_transaction": "199523"
    },
    {
      "id": 123315,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-29",
      "transaction_shares": "1274",
      "transaction_price": "194.12",
      "transaction_type": "F",
      "shares_after_transaction": "199523"
    },
    {
      "id": 171902,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-29",
      "transaction_shares": "1274",
      "transaction_price": "194.12",
      "transaction_type": "F",
      "shares_after_transaction": "199523"
    },
    {
      "id": 80728,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2189",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26215"
    },
    {
      "id": 80738,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2009",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16981"
    },
    {
      "id": 80739,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1958",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10434"
    },
    {
      "id": 80750,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1700",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7574"
    },
    {
      "id": 80768,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "3812",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44067"
    },
    {
      "id": 80773,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "670",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8508"
    },
    {
      "id": 80783,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9037"
    },
    {
      "id": 123312,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2189",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26215"
    },
    {
      "id": 123322,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2009",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16981"
    },
    {
      "id": 123323,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1958",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10434"
    },
    {
      "id": 123335,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1700",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7574"
    },
    {
      "id": 123353,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "3812",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44067"
    },
    {
      "id": 123358,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "670",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8508"
    },
    {
      "id": 123369,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9037"
    },
    {
      "id": 171899,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2189",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26215"
    },
    {
      "id": 171909,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2009",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16981"
    },
    {
      "id": 171910,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1958",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10434"
    },
    {
      "id": 171922,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-05-26",
      "transaction_shares": "1700",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7574"
    },
    {
      "id": 171942,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "3812",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44067"
    },
    {
      "id": 171948,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-05-26",
      "transaction_shares": "670",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8508"
    },
    {
      "id": 171962,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2023-05-26",
      "transaction_shares": "2215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9037"
    },
    {
      "id": 80725,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11167"
    },
    {
      "id": 80729,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-15",
      "transaction_shares": "345",
      "transaction_price": "190.39",
      "transaction_type": "S",
      "shares_after_transaction": "24026"
    },
    {
      "id": 80732,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22528"
    },
    {
      "id": 80740,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7335"
    },
    {
      "id": 80743,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31381"
    },
    {
      "id": 80761,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2484"
    },
    {
      "id": 80765,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3406"
    },
    {
      "id": 80766,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5628"
    },
    {
      "id": 80772,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-15",
      "transaction_shares": "3811",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "9829"
    },
    {
      "id": 80782,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "908"
    },
    {
      "id": 80788,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2459"
    },
    {
      "id": 80791,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65099"
    },
    {
      "id": 123309,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11167"
    },
    {
      "id": 123313,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-15",
      "transaction_shares": "345",
      "transaction_price": "190.39",
      "transaction_type": "S",
      "shares_after_transaction": "24026"
    },
    {
      "id": 123316,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22528"
    },
    {
      "id": 123324,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7335"
    },
    {
      "id": 123328,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31381"
    },
    {
      "id": 123346,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2484"
    },
    {
      "id": 123350,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3406"
    },
    {
      "id": 123351,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5628"
    },
    {
      "id": 123357,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-15",
      "transaction_shares": "3811",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "9829"
    },
    {
      "id": 123368,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "908"
    },
    {
      "id": 123376,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2459"
    },
    {
      "id": 123379,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65099"
    },
    {
      "id": 171896,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11167"
    },
    {
      "id": 171900,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-15",
      "transaction_shares": "345",
      "transaction_price": "190.39",
      "transaction_type": "S",
      "shares_after_transaction": "24026"
    },
    {
      "id": 171903,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22528"
    },
    {
      "id": 171911,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7335"
    },
    {
      "id": 171915,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31381"
    },
    {
      "id": 171934,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2484"
    },
    {
      "id": 171938,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3406"
    },
    {
      "id": 171939,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5628"
    },
    {
      "id": 171946,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-05-15",
      "transaction_shares": "3811",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "9829"
    },
    {
      "id": 171961,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "908"
    },
    {
      "id": 171969,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2459"
    },
    {
      "id": 171972,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-15",
      "transaction_shares": "664",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65099"
    },
    {
      "id": 80787,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-12",
      "transaction_shares": "950",
      "transaction_price": "193.02",
      "transaction_type": "S",
      "shares_after_transaction": "24380"
    },
    {
      "id": 123375,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-12",
      "transaction_shares": "950",
      "transaction_price": "193.02",
      "transaction_type": "S",
      "shares_after_transaction": "24380"
    },
    {
      "id": 171968,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-05-12",
      "transaction_shares": "950",
      "transaction_price": "193.02",
      "transaction_type": "S",
      "shares_after_transaction": "24380"
    },
    {
      "id": 80792,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-11",
      "transaction_shares": "288",
      "transaction_price": "193.43",
      "transaction_type": "S",
      "shares_after_transaction": "4964"
    },
    {
      "id": 123380,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-11",
      "transaction_shares": "288",
      "transaction_price": "193.43",
      "transaction_type": "S",
      "shares_after_transaction": "4964"
    },
    {
      "id": 171973,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-11",
      "transaction_shares": "288",
      "transaction_price": "193.43",
      "transaction_type": "S",
      "shares_after_transaction": "4964"
    },
    {
      "id": 46448,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 80763,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 123348,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 171936,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 46465,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 80789,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 123377,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 171970,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 46438,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 46442,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 46445,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 46454,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 46460,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 46466,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 80749,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 80755,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 80759,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 80774,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 80780,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 80790,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 123334,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 123340,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 123344,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 123359,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 123366,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 123378,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 171921,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 171927,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 171932,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 171949,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 171958,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 171971,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 46428,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 46449,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 80734,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 80764,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 123318,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 123349,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 171905,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 171937,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 46456,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 80776,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 123361,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 171953,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 46455,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 80775,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 123360,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 171952,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 46436,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 46437,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 46439,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 46441,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 46447,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 46468,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 80747,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 80748,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 80751,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 80754,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 80762,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 80794,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 123332,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 123333,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 123336,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 123339,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 123347,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 123382,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 171919,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 171920,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 171923,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 171926,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 171935,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 171975,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 24152,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 46467,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 80793,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 123381,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 171974,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 24132,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 46430,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 80737,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 123321,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 171908,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-12-02",
      "transaction_shares": "1500",
      "transaction_price": "218.90",
      "transaction_type": "P",
      "shares_after_transaction": "20114"
    },
    {
      "id": 24141,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 46450,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 80767,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 123352,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 171940,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-12-01",
      "transaction_shares": "6409",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "26641"
    },
    {
      "id": 24147,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 46459,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 80779,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 123365,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 171957,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-11-16",
      "transaction_shares": "855",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "7293"
    },
    {
      "id": 24136,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 46435,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 80746,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 123331,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 171918,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2022-11-15",
      "transaction_shares": "2279",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "4778"
    },
    {
      "id": 24128,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 46425,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 80727,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 123311,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 171898,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-11-04",
      "transaction_shares": "534",
      "transaction_price": "216.36",
      "transaction_type": "S",
      "shares_after_transaction": "20232"
    },
    {
      "id": 9552,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 24138,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 46443,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 80757,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 123342,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 171930,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-07-06",
      "transaction_shares": "195",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "20966"
    },
    {
      "id": 24143,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 46452,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 80770,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 123355,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 171944,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2022-06-07",
      "transaction_shares": "391",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "3803"
    },
    {
      "id": 46433,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 80744,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 123329,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 171916,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-06-06",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "211711"
    },
    {
      "id": 731,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 9549,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 24134,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 46432,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 80742,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 123327,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 171914,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2022-05-29",
      "transaction_shares": "1311",
      "transaction_price": "244.41",
      "transaction_type": "F",
      "shares_after_transaction": "213711"
    },
    {
      "id": 726,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 733,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 738,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 739,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 743,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 9544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 9551,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 9557,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 9558,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 9562,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 24127,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 24137,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 24145,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 24146,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 24151,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 46424,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 46440,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 46457,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 46458,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 46464,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 80726,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 80753,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 80777,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 80778,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 80786,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 123310,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 123338,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 123362,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 123364,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 123373,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 171897,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1493",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11263"
    },
    {
      "id": 171925,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6822"
    },
    {
      "id": 171954,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2022-05-27",
      "transaction_shares": "1657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21509"
    },
    {
      "id": 171956,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2022-05-27",
      "transaction_shares": "491",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6529"
    },
    {
      "id": 171966,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2022-05-27",
      "transaction_shares": "2455",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "36124"
    },
    {
      "id": 728,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 729,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 730,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 734,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 735,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 736,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 737,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 740,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 742,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 9546,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 9547,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 9548,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 9553,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 9554,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 9555,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 9556,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 9559,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 9561,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 24130,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 24131,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 24133,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 24139,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 24140,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 24142,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 24144,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 24148,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 24150,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 46427,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 46429,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 46431,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 46444,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 46446,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 46451,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 46453,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 46461,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 46463,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 80733,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 80735,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 80741,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 80758,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 80760,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 80769,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 80771,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 80781,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 80785,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 123317,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 123319,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 123325,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 123343,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 123345,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 123354,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 123356,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 123367,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 123372,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 171904,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1795"
    },
    {
      "id": 171906,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1528"
    },
    {
      "id": 171912,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2742"
    },
    {
      "id": 171931,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "549",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10211"
    },
    {
      "id": 171933,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "BERTOLINI ROBERT J",
      "reporting_owner_cik": "0001270263",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30312"
    },
    {
      "id": 171943,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kochevar Deborah Turner",
      "reporting_owner_cik": "0001448579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6671"
    },
    {
      "id": 171945,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18254"
    },
    {
      "id": 171960,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5252"
    },
    {
      "id": 171965,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "REESE C RICHARD",
      "reporting_owner_cik": "0001032365",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-11",
      "transaction_shares": "575",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64053"
    },
    {
      "id": 741,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 9560,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 24149,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 46462,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 80784,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 123371,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 171964,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MASSARO GEORGE",
      "reporting_owner_cik": "0001221496",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-09",
      "transaction_shares": "24",
      "transaction_price": "228.62",
      "transaction_type": "S",
      "shares_after_transaction": "4831"
    },
    {
      "id": 732,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 9550,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 24135,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 46434,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 80745,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 123330,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    },
    {
      "id": 171917,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP",
      "transaction_date": "2022-05-02",
      "transaction_shares": "5185",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5185"
    }
  ]
}